| # | Drug | Count |
|---|---|---|
| 0 | UPADACITINIB | 3 |
| 1 | DUPILUMAB | 2 |
| 2 | ADALIMUMAB | 1 |
| 3 | ADAPALENE | 1 |
| 4 | BACLOFEN | 1 |
| 5 | ETANERCEPT | 1 |
| 6 | FEXOFENADINE HYDROCHLORIDE | 1 |
| 7 | FEXOFENADINE HYDROCHLORIDE ORAL | 1 |
| 8 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 1 |
| 9 | FUROSEMIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TISOTUMAB VEDOTIN | 1 | 0.0010 |
| 1 | SOTATERCEPT-CSRK | 1 | 0.0002 |
| 2 | VORTIOXETINE | 1 | 0.0001 |
| 3 | FEXOFENADINE HYDROCHLORIDE | 1 | 0.0000 |
| 4 | UPADACITINIB | 3 | 0.0000 |
| 5 | LISDEXAMFETAMINE DIMESYLATE | 1 | 0.0000 |
| 6 | OFATUMUMAB | 1 | 0.0000 |
| 7 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 1 | 0.0000 |
| 8 | MACITENTAN | 1 | 0.0000 |
| 9 | ONABOTULINUMTOXINA | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 1 | Janus Kinase Inhibitor [EPC] | 3 | 0.0000 |
| 2 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 3 | Acetylcholine Release Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Prostacycline Vasodilator [EPC] | 1 | 0.0000 |
| 6 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 7 | Endothelin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Retinoid [EPC] | 1 | 0.0000 |
| 9 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2 | 0.0000 |